Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical Trial
Alpha Tau Medical Ltd. announced the successful treatment of the first patient in its European ACAPELLA clinical trial using Alpha DaRT combined with capecitabine for inoperable locally advanced pancreatic cancer. This trial complements ongoing U.S. studies as part of a global expansion strategy to improve outcomes in a cancer type with very limite…